Evaluation and appraisal of randomized controlled trials in myeloma
Open Access
- 1 November 2001
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 12 (11), 1611-1617
- https://doi.org/10.1023/a:1013181331874
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The uncertainty principle and industry-sponsored researchThe Lancet, 2000
- Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in OncologyJAMA, 1999
- The quality of medical evidence in hematology-oncologyAmerican Journal Of Medicine, 1999
- Bias in the Analysis and Reporting of Randomized Controlled TrialsInternational Journal of Technology Assessment in Health Care, 1996
- Assessing the Quality of Randomized Controlled Trials:Current Issues and Future DirectionsInternational Journal of Technology Assessment in Health Care, 1996
- Introduction: The Quality of the Medical Evidence: Is It Good Enough?International Journal of Technology Assessment in Health Care, 1996
- Empirical Evidence of BiasJAMA, 1995
- Systematic Reviews: Identifying relevant studies for systematic reviewsBMJ, 1994
- The Science of Reviewing ResearchaAnnals of the New York Academy of Sciences, 1993
- How study design affects outcomes in comparisons of therapy. I: MedicalStatistics in Medicine, 1989